![Vesa Matti Laakso](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vesa Matti Laakso
Private Equity Investor bei EduImpact Venture Capital Oy
Ursprung des Netzwerks ersten Grades von Vesa Matti Laakso
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
EduImpact Venture Capital Oy
![]() EduImpact Venture Capital Oy Investment ManagersFinance EduImpact Venture Capital Oy (EduImpact) is a venture capital firm founded in 2017 by Marko Kyyrönen, Antti Korhonen and Janne Rainvuori. The firm is headquartered in Helsinki, Finland.
3
| Private Company | Investment Managers | 3 |
Aura Capital Oy
![]() Aura Capital Oy Investment ManagersFinance Aura Capital Oy (Aura Capital) is a private equity/venture capital subsidiary of Auratum Oy founded in 1997. The firm is headquartered in Turku, Finland.
1
| Subsidiary | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Vesa Matti Laakso
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Helsinki | College/University | Graduate Degree Undergraduate Degree | |
FIM Bank Oy
![]() FIM Bank Oy Investment Banks/BrokersFinance Part of S-Group, FIM Bank Oy is a Finnish company that provides brokerage services. The company is based in Helsinki, Finland. Teri Tapio Heilala has been the CEO of the company since 2007. | Investment Banks/Brokers | Analyst-Equity | |
UB Asset Management Ltd.
![]() UB Asset Management Ltd. Investment ManagersFinance UB Asset Management Ltd. (UB AM) is the investment management subsidiary of United Bankers Oyj (HEL: UNITED) in Finland. Headquartered in Helsinki, UB AM was founded in 1995 and offers expert and reliable investment services for the various needs of investors. | Investment Managers | Portfolio Manager-Equities | |
E. Öhman J :or Fonder AB
![]() E. Öhman J :or Fonder AB Investment ManagersFinance E. Öhman J:or Fonder AB (Öhman Fonder) is the wholly-owned fund management subsidiary of E. Öhman J:or Asset Management AB, itself a subsidiary of the Dinkelspeil family's E. Öhman J:or AB in Sweden. Formerly known as SalusAnsvar E Öhman Fonder, the firm was founded in 1947 and became E. Öhman J:or Fonder AB in 2005. Headquartered in Stockholm, Öhman Fonder offers fund management and discretionary portfolio management to institutions, insurance companies and wealthy individuals. | Investment Managers | Portfolio Manager-Equities | |
Quorum VAR Oy
![]() Quorum VAR Oy Investment ManagersFinance Part of Evli Plc, Quorum VAR Oy is a Finnish company that provides investment advice. The company is based in Helsinki, Finland. The company was founded in 2005. Marko Eino Tapio Kyyrönen has been the CEO of the company since 2013. | Investment Managers | Chief Executive Officer | |
Optomed Software Oy
![]() Optomed Software Oy Packaged SoftwareTechnology Services Optomed Software Oy develops and sells proprietary software solutions for healthcare organizations. It offers products for workflow, resource and quality management within radiological or surgical departments or any screening or follow-up program. The company was founded in 1989 and is headquartered in Espoo, Finland. | Packaged Software | Director/Board Member | |
IP Finland Oy
![]() IP Finland Oy Miscellaneous Commercial ServicesCommercial Services IP Finland Oy provides research and development services. It specializes in the commercialization of research-based intellectual property. The company is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chairman | |
Leia Media Oy | Director/Board Member | ||
Aalto University School of Science & Technology | College/University | Undergraduate Degree | |
CanopyLAB A/S
![]() CanopyLAB A/S Packaged SoftwareTechnology Services CanopyLAB A/S operates an educational technology platform. The company was founded by Sahra-Josephine Hjorth, Christian Skræm Juul Jensen and Esben Trier in 2015 and is headquartered in Hvidovre, Denmark. | Packaged Software | Chairman |
Statistik
International
Finnland | 12 |
Schweden | 2 |
Dänemark | 2 |
Sektoral
Finance | 5 |
Consumer Services | 3 |
Technology Services | 3 |
Commercial Services | 3 |
Electronic Technology | 2 |
Operativ
Private Equity Investor | 4 |
Chief Executive Officer | 3 |
Founder | 3 |
Director/Board Member | 3 |
Chairman | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Vesa Matti Laakso
- Unternehmensverbindungen